Login / Signup

Overall survival after PARP maintenance treatment in platinum-sensitive relapsed ovarian cancer: opposing views of the US Food and Drug Administration and European Medicines Agency.

Bradley J MonkRobert L ColemanMansoor Raza Mirza
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Keyphrases
  • drug administration
  • acute lymphoblastic leukemia
  • dna damage
  • diffuse large b cell lymphoma
  • acute myeloid leukemia
  • hodgkin lymphoma
  • multiple myeloma
  • dna repair
  • risk assessment
  • climate change